(untitled) - von Hagens, C; Walter-Sack, I; Goeckenjan, M (Breast Cancer Res Treat, 2017)
et al. Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2).